PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $23,946,036 | +8.4% | 783,062 | +3.1% | 0.09% | +9.9% |
| Q1 2024 | $22,090,393 | -2.2% | 759,381 | -7.4% | 0.08% | -9.0% |
| Q4 2023 | $22,592,200 | +482.0% | 819,746 | +373.2% | 0.09% | +368.4% |
| Q3 2023 | $3,882,152 | -24.4% | 173,233 | +69.3% | 0.02% | -32.1% |
| Q3 2022 | $5,135,000 | +570.4% | 102,299 | +432.1% | 0.03% | +600.0% |
| Q4 2021 | $766,000 | -21.4% | 19,226 | -16.6% | 0.00% | -42.9% |
| Q2 2021 | $974,000 | -62.0% | 23,040 | -57.4% | 0.01% | -63.2% |
| Q1 2021 | $2,561,000 | +90.1% | 54,091 | +79.2% | 0.02% | -51.3% |
| Q1 2020 | $1,347,000 | -73.8% | 30,186 | -71.8% | 0.04% | -61.0% |
| Q4 2019 | $5,143,000 | +1101.6% | 107,069 | +759.2% | 0.10% | +426.3% |
| Q4 2018 | $428,000 | -34.6% | 12,461 | -49.1% | 0.02% | -38.7% |
| Q3 2015 | $654,000 | -91.1% | 24,503 | -79.8% | 0.03% | -91.3% |
| Q1 2015 | $7,382,000 | – | 121,315 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 8,180 | $382,000 | 7.47% |
| Burrage Capital Management LLC | 173,545 | $8,113,000 | 6.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 299,000 | $13,951,000 | 4.50% |
| RTW INVESTMENTS, LP | 3,993,286 | $186,686,000 | 4.50% |
| SECTORAL ASSET MANAGEMENT INC | 669,578 | $31,303,000 | 2.69% |
| Third Security, LLC | 255,873 | $11,962,000 | 2.48% |
| Sofinnova Investments, Inc. | 405,152 | $18,941,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 724,000 | $33,847,000 | 1.23% |
| Redwood Investments, LLC | 225,355 | $10,535,000 | 0.89% |
| Handelsinvest Investeringsforvaltning | 60,000 | $2,805,000 | 0.53% |